RE:FDA Ruling and Statement an absolute grand slam for Tetra!Hey Leaf, that FDA statement is literally the reason I bought a solid chunk of shares in Tetra about a year and a half ago. I think the majority of us longs were well aware that the current "medical" market was going to be reevaluated in light of serious clinical trial data being produced. Really glad to have a big position in the first company to complete clinical trials on smokeable cannabis, as well as three different oils with varying proportions of THC/CBD. Think about it, if you're a health care practitioner, would you prescribe medication that has empirical data to support its use? Or would you prescribe medication that relies on anecdotal information to support its use? It's an easy question to answer. Looking forward to the next couple of years.
LeafRider wrote: Boys, what's all this fuss about, oh this one is juicy!!! I think this very letter has quoted what I"ve been saying for over a year. I'm sorry if that seems like gloating, but I feel like I'm finally starting to hear what some of us have been preaching all along. This thing will eventually take off. GW Pharma is a force in pharma now, this was a huge ruling. If they can cross test various ailments now with an approved pure CBD that is a good 1st to market advantage. What the great thing is is it's not that easy, unless you do the clinicals and show the data on everything.
This is a piece in the article from the FDA.
"...The FDA says about cannabis drug development, the drug is being delivered to patients in a reliable dosage form and through a reproducible route of delivery to ensure that patients derive the anticipated benefits. This is how sound medical science is advanced.
THIS WHAT I'VE BEEN SAYING FOR OVER A YEAR ALEADY, it's exactly what Tetra is doing here. They are on their way now all it takes is money and couple home runs and we're good.
Only a matter of time until this pays off. I'm holding on for the ride, my uncle said when I told him about the company Tetra, he had a similar feeling to when gold was $200 an ounce and he tossed a bunch of money at it. At some point the story starts to sound really good to all of different people who are looking for that next big winner. No better way than with a pharma drug company.
GW Pharma was $97 when I was following them, I couldn't even consider buying at $97 a share in fear it was going to go to $15 or something crazy, just didn't understand the market cap either, but I sue do now, so it's clear that potential eventually gets priced into a share price. Tetra, has ZERO forecasted sales built within the share price. Which is a sad reality, but we don't... I bet GW pharma hits $200 by this time next year. They will eventually do a reverse split to make things more manageable / raise capital for the next drug. Dilution will always take place or clinicals, but the rewards are astronomical.
We're not an LP, so what... There is big money in science and pharma.
PPP001, 002, 003, 004, and 005 here we come... 3 ratios of cannabis oil in a phase 4 clinical trial as we speak!!! Could you imagine if we drop cannabis oil into a Pre-DIN# category well before schedule based on our knowledge of everything for PPP001, 002 etc.
All for now, even if this thing hovers at 70 like it has for months, I'm jacked for this investment. I'm not selling a single one period, Aphria's on my chopping block... $14.40 Aphria was equal to $0.90's Tetra when we walked down the ladder after the highs. I try to keep that in context, but maybe Tetra should actually market this a little bit. I urge all of you to encourage Tetra to talk about how well we support the FDA's stance on approving medicine for various ailments. I should've bought more warrants, think we'll get one more dip? - Cheers!